Cargando…
A risk model developed based on necroptosis to assess progression for ischemic cardiomyopathy and identify possible therapeutic drugs
Object: Ischemic cardiomyopathy (ICM), with high morbidity and mortality, is the most common cause of heart failure. Cardiovascular remodeling secondary to chronic myocardial ischemia is the main cause of its progression. A recently identified type of programmed cell death called necroptosis is cruc...
Autores principales: | Lu, Yang, Wang, Dashuai, Zhu, Yaoxi, Du, Yimei, Zhang, Jinying, Yang, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744324/ https://www.ncbi.nlm.nih.gov/pubmed/36518671 http://dx.doi.org/10.3389/fphar.2022.1039857 |
Ejemplares similares
-
Necroptosis in Pulmonary Diseases: A New Therapeutic Target
por: Wang, Lingling, et al.
Publicado: (2021) -
The Role of Necroptosis in Cardiovascular Disease
por: Zhe-Wei, Shi, et al.
Publicado: (2018) -
A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
por: Meng, Zilu, et al.
Publicado: (2022) -
Necroptosis: A Novel Pathway in Neuroinflammation
por: Yu, Ziyu, et al.
Publicado: (2021) -
The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy
por: Tang, Yaohan, et al.
Publicado: (2022)